H.R. 2197 — Introduced in House

I 119th CONGRESS 1st Session H. R. 2197 IN THE HOUSE OF REPRESENTATIVES March 18, 2025Mr. Johnson of South Dakota (for himself, Mr. Austin Scott of Georgia, Mr. Crenshaw, Mr. Rulli, Mr. Ezell, Mrs. Bice, Mr. Moore of Alabama, and Mr. Rose) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To prevent 340B covered entities from using savings derived for sex reassignment surgeries, hormonal therapies, and for other purposes. 1. Short title This Act may be cited as the No 340B Savings for Transgender Care Act. 2. Prohibition on use of 340b savings for services described for transgender individuals (a) Prohibition on use of 340B savings for services described Section 340B(a)(4) of the Public Health Service Act (42 U.S.C. 256b(a)(5)) is amended by adding at the end the following: (E) Prohibition on use of 340b savings for services described A covered entity participating in the program under this section may not use any funds derived from the difference between the 340B ceiling price and the actual acquisition cost of covered outpatient drugs to pay for services described. (i) Definitions For purposes of this subsection— (I) Covered entity The term covered entities has the meaning given such term in section 340B(a)(4). (II) Services described The term services described means— (aa) sex reassignment surgeries furnished for the purpose of the gender alteration of a transgender individual; and (bb) hormone treatments furnished for the purpose of the gender alteration of a transgender individual. .